Modulation ofLeishmania majoraquaglyceroporin activity by a mitogen-activated protein kinase-Reference-Cited by-同舟云学术

Modulation ofLeishmania majoraquaglyceroporin activity by a mitogen-activated protein kinase

Published:2012-07-26 Issue:6 Volume:85 Page:1204-1218
ISSN:0950-382X
Container-title:Molecular Microbiology
language:en
Short-container-title:

Author:

Mandal Goutam,Sharma Mansi,Kruse Martin,Sander-Juelch Claudia,Munro Laura A.,Wang Yong,Vilg Jenny Veide,Tamás Markus J.,Bhattacharjee Hiranmoy,Wiese Martin,Mukhopadhyay Rita

Publisher

Wiley

Subject

Molecular Biology,Microbiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2958.2012.08169.x/fullpdf

Reference37 articles.

1. Hyperosmolar mannitol simulates expression of aquaporins 4 and 9 through a p38 mitogen-activated protein kinase-dependent pathway in rat astrocytes;Arima;J Biol Chem,2003

2. LmxMPK9, a mitogen-activated protein kinase homologue affects flagellar length in Leishmania mexicana;Bengs;Mol Microbiol,2005

3. Aquaglyceroporins and metalloid transport: implications in human diseases;Bhattacharjee;Handb Exp Pharmacol,2009

4. Parasite mitogen-activated protein kinases as drug discovery targets to treat human protozoan pathogens;Brumlik;J Signal Transduct,2011

5. Osmotic regulation of gene expression;Burg;FASEB J,1996

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing approved protein kinase inhibitors as potent anti-leishmanials targeting Leishmania MAP kinases;Life Sciences;2024-08

2. Leishmania donovani mitogen-activated protein kinases as a host-parasite interaction interface;Cytokine;2024-07

3. Expression of glucose (GLUT) and glycerol (GLP) transporters in symbiotic and bleached Cassiopea xamachana (Bigelow, 1892) jellyfish;Marine Biology;2024-01-12

4. Antimony resistance and gene expression in Leishmania: spotlight on molecular and proteomic aspects;Parasitology;2023-11-28

5. An integrative in silico and in vitro study identifies Leishmania donovani MAP kinase12 as a probable virulence factor;International Immunopharmacology;2023-08